Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antagonism
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Small Arteries
100%
Angiotensin Type I Receptor
100%
Candesartan
100%
Angiotensin II Type 1 Receptor (AT1R)
100%
Type 2 Diabetic Patients
100%
Dilatation
50%
Endothelial Dysfunction
50%
Acetylcholine
50%
Angiotensin Receptor Blockade
50%
Pre-diabetes (pre-DM)
50%
Placebo-controlled
25%
Brief Therapy
25%
Group Studies
25%
Hypertension
25%
Nitric Oxide
25%
Endothelial Function
25%
Pressure Myography
25%
Vasoconstriction
25%
Endothelium-independent
25%
Sodium Nitroprusside
25%
Maximum Response
25%
EC50
25%
Resistance Vessels
25%
Vascular Reactivity
25%
Vessel Function
25%
Angiotensin II (Ang II)
25%
Low-density Lipoprotein Cholesterol Level
25%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Candesartan
100%
Angiotensin 1 Receptor
100%
Patient with Type 2 Diabetes
100%
Diabetes Mellitus
66%
Endothelial Dysfunction
66%
Acetylcholine
66%
Receptor Blocking
66%
Angiotensin Receptor
66%
Placebo
33%
Nitric Oxide
33%
Vasoconstriction
33%
Noradrenalin
33%
Low Density Lipoprotein Cholesterol
33%
Myography
33%
Candesartan Hexetil
33%
Resistance Vessel
33%
Sodium Nitroprusside
33%
Endothelial Function
33%
Angiotensin II
33%
Blood Vessel Reactivity
33%
Hypertension
33%
Endothelium
33%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin 1 Receptor
100%
Candesartan
100%
Maturity Onset Diabetes of the Young
100%
Diabetes Mellitus
66%
Endothelial Dysfunction
66%
Acetylcholine
66%
Angiotensin Receptor
66%
Placebo
33%
Noradrenalin
33%
Low Density Lipoprotein Cholesterol
33%
Nitroprusside Sodium
33%
Angiotensin II
33%
Candesartan Hexetil
33%
Nitric Oxide
33%
EC50
33%
Hypertension
33%
Neuroscience
Candesartan
100%
Angiotensin II Receptor Type 1
100%
Sodium Nitroprusside
25%
Immunology and Microbiology
Angiotensin
100%
EC50
25%
Blood Vessel Reactivity
25%